The University of Dundee found huge success at this years Courier Business Awards with three of their spin-out companies winning awards. Exscientia was named Science and Technology Business of the Year while MyWay Digital Health won the Enterprise in Education prize and STAR-Dundee took the Design and Innovation Business of the Year accolade. The Courier Business Awards celebrates business and individuals from across Tayside, Fife, Perthshire and Angus whose entrepreneurial...
A new precision medicine study for prostate cancer is set to be launched today by men’s health charity, Prostate Cancer UK. The study will be co-lead by researchers from the University of Glasgow and will aim to drive tailor made treatments for men based on the genetic make-up of their cancer. By developing this research and moving away from a “one size fits all” approach,...
Concept Life Sciences (Concept), announced they have acquired Aquila BioMedical (Aquila), an innovative pre-clinical contract research organisation with expertise in immuno-oncology, immunology and multiplex histology. Aquila develop therapeutics for oncology, biomarker discovery and target expression, with services covering a wide range of in vitro and in vivo proof-of-concept studies. The acquisition will be a significant addition to the range of integrated services Concept provide as...
The International Campus at Haining, Zhejiang Province, will accommodate 5,000 students and bring together researchers and teaching staff from both Edinburgh and Zhejiang Universities. The campus will deliver a four-year degree in Biomedical Sciences – the first of its kind in China. The curriculum will cover infectious diseases, neuroscience, pharmacology, physiology and reproductive biology. The Zhejiang University – University of Edinburgh Institute will also have...
Leishmania is a parasite that infects 1 million people each year causing 20,000-30,000 deaths. Researcher’s from the University of Edinburgh have made a discovery that has improved scientists understanding of how the parasite functions and as a result how to target the infectious parasite. The Leishmania parasite tends to be found in the tropics and subtropics of Europe and is transmitted through infected sandflies. The...
Exscientia Ltd received €15 million investment from Evotec AG giving them a minority stake. Exscientia is focused on Artificial Intelligence (AI) driven drug discovery and design. Evotec and Exscientia have worked in partnership since early 2016, the success of this relationship is the basis of this investment allowing further advances in their immuno-oncology therapeutic research in the future. To read the full article, click here.